>latest-news

Mr. Mayur Hedaoo Appointe d as Group CEO of Fablab, Strengthening Vision for Global Pharma and Healthcare Innovation

Fablab names Mayur Hedaoo as Group CEO, advancing its global pharma & healthcare innovation with tech-driven, purpose-led leadership.

Breaking News

  • Apr 29, 2025

  • Simantini Singh Deo

Mr. Mayur Hedaoo Appointe d as Group CEO of Fablab, Strengthening Vision for Global Pharma and Healthcare Innovation

Mumbai, India / Dubai, UAE — 29th Apr, 2025 – Fablab, a leading player in pharma and healthcare innovation, proudly announces the appointment of Mr. Mayur Hedaoo as its new Group Chief Executive Officer (CEO).

With a proven track record of building scalable ecosystems across the pharmaceutical, biopharmaceutical, and allied industries, Mr. Hedaoo brings a powerful blend of strategic vision, operational excellence, and innovation-driven leadership to Fablab's global growth journey.


A Strategic Move for a Healthier Tomorrow Having previously spearheaded international business growth at Bectochem Lödige Process Technology for over a decade, Mr. Hedaoo’s leadership has been marked by successful global expansions, strategic partnerships, operational transformations, and an unwavering focus on customer-centric innovation.

In his new role as Group CEO, Mr. Hedaoo will lead Fablab’s efforts to strengthen its position as a catalyst for future-ready pharma and healthcare ecosystems — with a core focus on sustainability, technological innovation, and impactful collaboration. "Our mission at Fablab is clear: to transform pharma and healthcare innovation for a healthier tomorrow. I am honored to lead a team committed to building scalable platforms that converge technology, people, and purpose, while addressing real-world healthcare challenges across global markets," said Mr. Mayur Hedaoo.


A New Era of Growth and Purpose for Fablab

As Fablab embarks on its next phase of growth, Mr. Hedaoo’s appointment reflects the company’s ambition to evolve beyond traditional boundaries fostering innovation not just for industry needs today, but for the sustainable healthcare solutions of tomorrow.

The leadership transition reinforces Fablab's commitment to:

  • Expanding global footprints in pharma, biopharma, and healthcare innovation

  • Scaling collaboration-driven ecosystems with industry, startups, and academia

  • Leading transformation with purpose, technology, and operational excellence

About Fablab

Fablab is a leading platform enabling pharma, healthcare, and allied industries to build future-ready innovation ecosystems. Headquartered in Mumbai, with a growing presence in Dubai and emerging global markets, Fablab specializes in transforming operational excellence, fostering sustainable innovations, and building collaborative growth platforms for a healthier tomorrow.

Ad
Advertisement